[HTML][HTML] The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature
Precision oncology and pharmacogenomics (PGx) intersect in their overarching goal to
institute the right treatment for the right patient. However, the translation of these innovations …
institute the right treatment for the right patient. However, the translation of these innovations …
增生性瘢痕差异表达基因及小分子药物预测的生物信息学分析与验证
左俊， 马少林 - 中国组织工程研究, 2024 - cjter.com
增生性瘢痕差异表达基因及小分子药物预测的生物信息学分析与验证 Page 1 2166|中国组织工程
研究|第28卷|第14期|2024年5月 中国组织工程研究 Chinese Journal of Tissue Engineering …
研究|第28卷|第14期|2024年5月 中国组织工程研究 Chinese Journal of Tissue Engineering …
Bioinformatics analysis and validation of differentially expressed genes and small molecule drug prediction in proliferative scar
J Zuo, S Ma - Chinese Journal of Tissue Engineering Research, 2024 - cjter.com
BACKGROUND: Hypertrophic scar is a skin fibrosis disease characterized by excessive
proliferation of fibroblasts, epidermal thickening, and stratum corneum dysfunction. At …
proliferation of fibroblasts, epidermal thickening, and stratum corneum dysfunction. At …